DUGGAN ROBERT W bought SMMT
September 11, 2025 · Form 4 insider transaction
DUGGAN ROBERT W bought 5,000 shares of Summit Therapeutics Inc. at $18.07 per share, a transaction worth $90.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$18.07
Total value
$90.3K
InsiderDUGGAN ROBERT W
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 11, 2025
Filing dateSeptember 11, 2025
Shares owned after556,093,090
OwnershipDirect
10b5-1 planNo
AmendedNo